Elsie Biotechnologies
Elsie Biotechnologies
Unlocking Early Success: Choose the Best Biologics!
BIOT
Unlock the secrets to identifying top biologic candidates early! 🚀 Enhance decision-making with innovative strategies and efficient evaluations. 🔍🧬📊
GSK’s $50m Acquisition Revolutionizes Oligonucleotide Drug Development
BIOT
📢 GSK acquires Elsie Biotechnologies in a $50m deal to enhance its drug platform and develop treatments for difficult-to-treat diseases. 🧬👥🚀
